Johnson & Johnson said the FDA approved the TECNIS PureSee intraocular lens for use in cataract surgery. The company said the lens is an extended depth of focus option intended to address cataract-related vision loss and presbyopia. Johnson & Johnson said 97% of patients reported no very bothersome visual disturbances in a study referenced in the announcement.

Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Johnson & Johnson published the original content used to generate this news brief via Business Wire (Ref. ID: 20260312338552) on March 12, 2026, and is solely responsible for the information contained therein.